Literature DB >> 26537534

Guidelines for good pharmacoepidemiology practice (GPP).

.   

Abstract

Mesh：

Year:  2015        PMID： 26537534     DOI： 10.1002/pds.3891

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  54 in total

1.  Concomitant use of drugs known to cause interactions with oral antiplatelets-polypharmacy in acute coronary syndrome outpatients in Finland.

Authors:  Tuire Prami; Houssem Khanfir; Pål Hasvold; Eeva Reissell; Juhani Airaksinen; Ville Kytö
Journal:  Eur J Clin Pharmacol       Date:  2019-11-26       Impact factor: 2.953

2.  Pharmacoepidemiology in the era of real-world evidence.

Authors:  Sengwee Toh
Journal:  Curr Epidemiol Rep       Date:  2017-10-19

Review 3.  Toward a better understanding about real-world evidence.

Authors:  Mei Liu; Yana Qi; Wen Wang; Xin Sun
Journal:  Eur J Hosp Pharm       Date:  2021-12-02

4.  Patient and Clinician Preferences for Genetic and Genomic Testing in Non-Small Cell Lung Cancer: A Discrete Choice Experiment.

Authors:  Simon Fifer; Robyn Ordman; Lisa Briggs; Andrea Cowley
Journal:  J Pers Med       Date:  2022-05-26

Review 5.  Interpreting the pharmacoepidemiology literature in obstetrical studies: A guide for clinicians.

Authors:  Laura J Rasmussen-Torvik; Katelyn B Zumpf; Hannah K Betcher; Jody D Ciolino
Journal:  Semin Perinatol       Date:  2020-02-28       Impact factor: 3.300

Review 6.  The Structured Process to Identify Fit-For-Purpose Data: A Data Feasibility Assessment Framework.

Authors:  Nicolle M Gatto; Ulka B Campbell; Emily Rubinstein; Ashley Jaksa; Pattra Mattox; Jingping Mo; Robert F Reynolds
Journal:  Clin Pharmacol Ther       Date:  2021-12-01       Impact factor: 6.903

7.  Treatment strategy, overall survival and associated risk factors among patients with unresectable stage IIIB/IV non-small cell lung cancer in China (2015-2017): A multicentre prospective study.

Authors:  Yuankai Shi; Xin Zhang; Gang Wu; Jianping Xu; Yong He; Dong Wang; Cheng Huang; Mingwei Chen; Ping Yu; Yan Yu; Wei Li; Qi Li; Xiaohua Hu; Jinjing Xia; Lilian Bu; Angela Yin; Yigong Zhou
Journal:  Lancet Reg Health West Pac       Date:  2022-04-11

8.  Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland.

Authors:  Tuire Prami; Houssem Khanfir; Anna Deleskog; Pål Hasvold; Ville Kytö; Eeva Reissell; Juhani Airaksinen
Journal:  BMJ Open       Date:  2016-11-22       Impact factor: 2.692

9.  Dispensing Patterns of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration: A Retrospective Cohort Study in Australia.

Authors:  Adrian Skelly; Hans-Joachim Carius; Vladimir Bezlyak; Fred K Chen
Journal:  Adv Ther       Date:  2017-11-21       Impact factor: 3.845

10.  Implementing an automated monitoring process in a digital, longitudinal observational cohort study.

Authors:  Lisa Lindner; Anja Weiß; Andreas Reich; Siegfried Kindler; Frank Behrens; Jürgen Braun; Joachim Listing; Georg Schett; Joachim Sieper; Anja Strangfeld; Anne C Regierer
Journal:  Arthritis Res Ther       Date:  2021-07-07       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.